Celso de Oliveira Rezende Junior

Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease.

L. Maes, A. Andricopulo, S. Michelan-Duarte, 2022, European journal of medicinal chemistry.

Synthetic Studies toward the Total Synthesis of Tautomycetin.

J. Campagne, L. Dias, Renata Marcia de Figueiredo, 2019, The Journal of organic chemistry.

Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors

Leonardo L. G. Ferreira, Leonardo L G Ferreira, A. Andricopulo, 2021, Biomolecules.

Discovery and structural optimization of a new series of N-acyl-2-aminobenzothiazole as inhibitors of Zika virus.

E. Pilau, Celso de Oliveira Rezende Junior, N. Cassani, 2023, Bioorganic & medicinal chemistry.

Discovery of Potent, Reversible and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach.

Mariana L. de Souza, Celso de Oliveira Rezende Junior, Rafaela Salgado Ferreira, 2019, Journal of chemical information and modeling.

Optimization of benzenesulfonyl derivatives as anti-Trypanosomatidae agents: Structural design, synthesis, and pharmacological assessment against Trypanosoma cruzi and Leishmania infantum.

Daniela de Melo Resende, Celso de Oliveira Rezende Junior, Silvane Maria Fonseca Murta, 2024, Bioorganic & medicinal chemistry.

New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease

Gustavo Henrique Goulart Trossini, S. Murta/, D. Liarte, 2024, Expert opinion on drug discovery.